Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
Year-over-year debt growth rate
5Y CAGR
-2.6%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 1.36% |
| Q3 2025 | -0.39% |
| Q2 2025 | -0.26% |
| Q1 2025 | 1.73% |
| Q4 2024 | -0.25% |
| Q3 2024 | -1.00% |
| Q2 2024 | -1.61% |
| Q1 2024 | 21.45% |
| Q4 2023 | -0.46% |
| Q3 2023 | 5.38% |
| Q2 2023 | -0.51% |
| Q1 2023 | -1.14% |
| Q4 2022 | -5.67% |
| Q3 2022 | -0.02% |
| Q2 2022 | 3.90% |
| Q1 2022 | -0.16% |
| Q4 2021 | 0.00% |
| Q3 2021 | -0.05% |
| Q2 2021 | -4.77% |
| Q1 2021 | 5.73% |
| Q4 2020 | 1.55% |
| Q3 2020 | -2.82% |
| Q2 2020 | 36.39% |
| Q1 2020 | -16.34% |
| Q4 2019 | -4.40% |
| Q3 2019 | 5.35% |
| Q2 2019 | 6.95% |
| Q1 2019 | 0.78% |
| Q4 2018 | -5.45% |
| Q3 2018 | -3.00% |
| Q2 2018 | -19.41% |
| Q1 2018 | -0.50% |
| Q4 2017 | 57.18% |
| Q3 2017 | 33.11% |
| Q2 2017 | 2.92% |
| Q1 2017 | 28.57% |
| Q4 2016 | -3.31% |
| Q3 2016 | -2.52% |
| Q2 2016 | -3.35% |
| Q1 2016 | 2.10% |